The Dividend Payout Ratio is the measure of dividends paid out to shareholders relative to the company's net income. It is calculated as the Dividends per Share divided by the Earnings per Share (Diluted) during the same time period. GlaxoSmithKline Pharmaceuticals's Dividend Payout Ratio for the
months ended in Mar. 2026 was 0.00.
The historical rank and industry rank for GlaxoSmithKline Pharmaceuticals's Dividend Payout Ratio or its related term are showing as below:
NSE:GLAXO'
s Dividend Payout Ratio Range Over the Past 10 Years
Min: 0.59 Med: 0.75 Max: 1.38
Current: 0.7
During the past 13 years, the highest Dividend Payout Ratio of GlaxoSmithKline Pharmaceuticals was 1.38. The lowest was 0.59. And the median was 0.75.
NSE:GLAXO's Dividend Payout Ratio is ranked worse than 81.98% of 444
companies
in the Drug Manufacturers industry
Industry Median: 0.375
vs NSE:GLAXO: 0.70
During the past 13 years, the highest Trailing Annual Dividend Yield of GlaxoSmithKline Pharmaceuticals was 4.27%. The lowest was 0.93%. And the median was 1.46%.
During the past 12 months, GlaxoSmithKline Pharmaceuticals's average Dividends Per Share Growth Rate was 31.30% per year.
During the past 3 years, the average Dividends Per Share Growth Rate was 11.90% per year.
During the past 5 years, the average Dividends Per Share Growth Rate was 12.00% per year.
During the past 10 years, the average Dividends Per Share Growth Rate was 5.80% per year.
During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of GlaxoSmithKline Pharmaceuticals was 45.80% per year. The lowest was -17.60% per year. And the median was 11.60% per year.
The growth rate is calculated with least square regression.
For more information regarding to dividend, please check our Dividend Page.
* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.
GlaxoSmithKline Pharmaceuticals (NSE:GLAXO) Dividend Payout Ratio Explanation
In dividends investing, Dividend Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.
GlaxoSmithKline Pharmaceuticals Dividend Payout Ratio Related Terms
GlaxoSmithKline Pharmaceuticals Dividend Payout Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
GlaxoSmithKline Pharmaceuticals Dividend Payout Ratio Chart
NSE:GLAXO vs LLY, JNJ, ABBV: Dividend Payout Ratio Comparison
For the Drug Manufacturers - General subindustry, GlaxoSmithKline Pharmaceuticals's Dividend Payout Ratio, along with its competitors' market caps and Dividend Payout Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
GlaxoSmithKline Pharmaceuticals Dividend Payout Ratio vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, GlaxoSmithKline Pharmaceuticals's Dividend Payout Ratio distribution charts can be found below:
* The bar in red indicates where GlaxoSmithKline Pharmaceuticals's Dividend Payout Ratio falls into.
GlaxoSmithKline Pharmaceuticals Dividend Payout Ratio Calculation
The Dividend Payout Ratio is the measure of dividends paid out to shareholders relative to the company's net income. It is calculated as the Dividends per Share divided by the Earnings per Share (Diluted) during the same time period.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
GlaxoSmithKline Pharmaceuticals (NSE:GLAXO) has a Dividend Payout Ratio of 0.00 as of Mar. 2026. Dividend payout ratio is the percent of company earnings paid out as dividends. View historical data on GlaxoSmithKline Pharmaceuticals and its competitors. Over the past decade, GlaxoSmithKline Pharmaceuticals' Dividend Payout Ratio has ranged from 0.59 to 1.38. According to the industry distribution chart, GlaxoSmithKline Pharmaceuticals ranks #364 out of 444 companies in the Drug Manufacturers industry, placing it in the top 82%.
Is GlaxoSmithKline Pharmaceuticals' Dividend Payout Ratio too high?
GlaxoSmithKline Pharmaceuticals' current Dividend Payout Ratio is 0.00. Over the past 10 years, this metric has ranged from a low of 0.59 to a high of 1.38. Based on the distribution chart, GlaxoSmithKline Pharmaceuticals ranks #364 out of 444 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, GlaxoSmithKline Pharmaceuticals has a GF Score™ of 74/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does GlaxoSmithKline Pharmaceuticals' Dividend Payout Ratio compare to LLY and JNJ?
According to the Drug Manufacturers industry distribution chart, GlaxoSmithKline Pharmaceuticals ranks #364 out of 444 companies for Dividend Payout Ratio. This places GlaxoSmithKline Pharmaceuticals in the lower half of its industry. The industry median Dividend Payout Ratio is 0.38. Historically, GlaxoSmithKline Pharmaceuticals' own Dividend Payout Ratio has ranged from 0.59 to 1.38 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Dividend Payout Ratio for a Drug Manufacturers company?
The median Dividend Payout Ratio among Drug Manufacturers companies is 0.38, based on 444 companies in the industry. Companies in the top quartile (top 25%) have a Dividend Payout Ratio significantly above this median, while those in the bottom quartile fall well below. However, Dividend Payout Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Dividend Payout Ratio mean?
A high Dividend Payout Ratio can signal that a stock is expensive relative to its fundamentals. Dividend payout ratio is the percent of company earnings paid out as dividends. View historical data on GlaxoSmithKline Pharmaceuticals and its competitors. For the Drug Manufacturers industry, the median Dividend Payout Ratio is 0.38 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. GlaxoSmithKline Pharmaceuticals's current Dividend Payout Ratio is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is GlaxoSmithKline Pharmaceuticals stock overvalued right now?
Based on GuruFocus' analysis, GlaxoSmithKline Pharmaceuticals (NSE:GLAXO) is currently considered Fairly Valued. The stock's GF Value™ is ₹2,617.84, compared to a current price of ₹2,450.30 — trading 6.4% below its estimated fair value. The current Dividend Payout Ratio is 0.00. GlaxoSmithKline Pharmaceuticals' overall GF Score™ is 74/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Dividend Payout Ratio calculated?
Dividend Payout Ratio is calculated from a company's financial statements. For GlaxoSmithKline Pharmaceuticals (NSE:GLAXO), the current Dividend Payout Ratio is 0.00 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is GlaxoSmithKline Pharmaceuticals (NSE:GLAXO) Overvalued in 2026?
Based on GuruFocus' analysis, GlaxoSmithKline Pharmaceuticals stock appears to be undervalued.
The current stock price of ₹2,450.30 is trading 6.4% below its estimated GF Value™ of ₹2,617.84.
GuruFocus considers GlaxoSmithKline Pharmaceuticals to be Fairly Valued.
Key valuation signals for NSE:GLAXO:
Dividend Payout Ratio: 0.00
GF Value™: ₹2,617.84 vs. price of ₹2,450.30 (6.4% below fair value)
No single metric tells the full story. See the NSE:GLAXO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
GlaxoSmithKline Pharmaceuticals Business Description
GlaxoSmithKline Pharmaceuticals Ltd is engaged interalia, in the business of manufacturing, distributing and trading in pharmaceuticals. It is healthcare organisation focused on uniting science, technology and talent to get ahead of disease. The company's product portfolio comprises a broad range of General Medicines which includes anti-infectives, pain management, vitamins, minerals, nutritionals, hormones, dermatologicals, vaccines for both children and adults, and specialty medicines for respiratory and oncology. Its focused brands are Augmentin, Ceftum, Flutivate, T-bat, Betnovate, Neosporin, Tenovate, Physiogel, Calpol and Calpol T. The company has single reportable segment. The company has presence in India, and also Outside India. It generates majority of revenue from India.
74GF Score
Get the complete analysis for NSE:GLAXO
Dividend Payout Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:GLAXO has been successfully added to your 
